Data Sources
Comprehensive overview of the data sources powering VIALLMED HUB pharmaceutical analytics.
Data Collection Methodology
VIALLMED HUB aggregates pharmaceutical data from multiple authoritative sources to provide comprehensive, accurate insights. Our data pipeline integrates clinical trial registries, regulatory databases, prescription tracking systems, and healthcare provider networks to deliver real-time intelligence on drug performance and market dynamics.
All data sources undergo rigorous validation and quality control processes to ensure accuracy, completeness, and timeliness. We continuously monitor source reliability and implement automated checks to detect anomalies and maintain data integrity.
Primary Data Sources
Comprehensive clinical trial data from ClinicalTrials.gov, EudraCT, and other international registries. Includes trial phases, enrollment status, outcomes, and safety reports.
Official FDA drug approvals, safety alerts, Orange Book listings, and regulatory guidance documents. Includes approval timelines, label changes, and post-market surveillance data.
Peer-reviewed research from leading medical journals including NEJM, The Lancet, JAMA, and specialty publications. Covers efficacy studies, real-world evidence, and comparative effectiveness research.
Aggregated prescription volume data from pharmacy networks and healthcare systems. Tracks prescribing patterns, market share, and utilization trends across therapeutic areas and geographic regions.
Professional sentiment and prescribing preferences from physician networks and healthcare institutions. Includes doctor surveys, treatment pattern analysis, and expert opinions on drug efficacy.
Commercial pharmaceutical market data including sales figures, market share, competitive positioning, and pricing information. Tracks market dynamics across global regions and therapeutic segments.
Data Quality & Verification
All data sources are vetted for reliability and accuracy. We prioritize official regulatory databases, peer-reviewed literature, and established industry data providers.
Continuous monitoring systems detect data anomalies, missing values, and inconsistencies. Automated alerts trigger manual review when quality thresholds are breached.
Critical data points are cross-referenced across multiple sources. Discrepancies trigger investigation and resolution before integration into our analytics platform.
Data Coverage Statistics
Clinical Trials
FDA Approved Drugs
Research Publications
Healthcare Providers
Our data pipeline processes millions of data points daily, ensuring VIALLMED HUB delivers the most comprehensive and current pharmaceutical intelligence available.
Data Access & Transparency
VIALLMED HUB is committed to transparency in our data sourcing and methodology. We clearly attribute data sources and maintain detailed documentation of our collection and validation processes.
For questions about specific data sources, methodologies, or to request access to source documentation, please contact our data team at data@viallmedhub.com.